Stocktoria

BIOVIE INC. BIVI

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2014-01-14

BIOVIE INC. statistics & valuation

Market cap$14.6M
P / B0.8×
Return on equity-92.3%
Return on capital-93.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-22.50% -115.00% -2189.00% -2579.00% -710.60% -327.60% -207.10% -92.30% 2016201720182019202020212022202320242025
Shares outstanding
87.2M 91.9M 98.5M 4.1M 5.2M 22.3M 25.0M 3.6M 619008 1.9M 2016201720182019202020212022202320242025
Net debt ($)
$62500 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-15.90% -56.30% -111.90% -800.30% -2154.10% -129.70% -143.20% -127.40% -81.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
-$0.98 -$6.85 -$14.82 -$1.06 -$15.47 -$73.05 -$12.12 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-81.4%-127.4%-143.2%-129.7%-2154.1%-800.3%—-111.9%-56.3%-15.9%
Return on equity-92.3%-207.1%-327.6%-710.6%-2579.0%77.6%—-2189.0%-115.0%-22.5%
Debt / equity—————-0.00×————
Current ratio9.102.572.354.504.620.021.520.040.010.16

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.